文献速递胃肠外科围术期管理与 ERAS

术前肌少症对局部进展期胃癌患者教科书肿瘤学结局的影响:多中心临床研究

Textbook oncological outcome of locally advanced gastric cancer patients with preoperative sarcopenia: a multicenter clinical study.
PubMed 文献 · Surg Endosc · 2024-11-15

本研究回顾性分析两所中国三级医院972例接受根治性手术的局部进展期胃癌(LAGC)患者,发现术前肌少症是教科书肿瘤学结局(TOO)实现的独立危险因素,且TOO实现率在无肌少症组显著更高(68.9% vs 61.1%,P=0.031)。整合肌少症与TOO的列线图可准确预测3年和5年总生存(OS)与无复发生存(RFS),且优于现行分期系统。

要点

  • 术前肌少症是LAGC患者TOO失败的独立危险因素。
  • 无肌少症患者TOO实现率显著高于肌少症患者(68.9% vs 61.1%,P=0.031)。
  • 整合肌少症与TOO的列线图可预测3年和5年OS及RFS。

核心结论

  • 术前肌少症是TOO实施的独立预测因素。
  • 整合术前肌少症和TOO的预后模型优于现行分期系统,可辅助评估LAGC患者预后。

研究设计与样本

  • 回顾性分析两所中国三级医院接受根治性手术的LAGC患者的临床和病理数据,共纳入972例。
  • 肌少症定义为男性SMI < 36.4 cm2/m2、女性SMI < 28.4 cm2/m2。
  • TOO定义为围术期化疗加入教科书结局(TO)。
  • 开发列线图预测术后OS和RFS。

主要发现

  • 总体TOO实现率为67.1%。
  • 无肌少症患者TOO实现率显著高于肌少症患者(68.9% vs 61.1%,P = 0.031)。
  • Logistic回归显示年龄≥65、高ASA评分和肌少症是TOO失败的独立危险因素。
  • Cox回归确定TOO、肌少症、肿瘤大小、分化、血管侵犯、pT分期和pN分期为OS和RFS的独立预测因素。
  • 基于肌少症和TOO的列线图模型可准确预测3年和5年OS和RFS。

关键数值与推荐

  • 肌少症诊断阈值:男性SMI < 36.4 cm2/m2,女性SMI < 28.4 cm2/m2。
  • TOO定义:围术期化疗加入教科书结局(TO)。

临床怎么用

  • 术前应评估肌少症以识别TOO失败高风险患者。
  • 可考虑使用整合肌少症和TOO的列线图预测LAGC患者术后生存。

局限性

  • 回顾性研究设计可能引入选择偏倚。
  • 样本来自两所中国三级医院,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of postoperative sarcopenia on the Textbook Oncological Outcome (TOO) in locally advanced gastric cancer (LAGC) remains uncertain. This study investigates the relationship between sarcopenia and TOO, explores its long-term prognostic value, and develops a prognostic model incorporating sarcopenia and TOO for survival prediction. METHODS: We performed a retrospective analysis of clinical and pathological data from patients with LAGC who underwent radical surgery at two Chinese tertiary referral hospitals. Sarcopenia was defined as an SMI < 36.4 cm2/m2 in males and < 28.4 cm2/m2 in females. TOO was defined as the addition of perioperative chemotherapy to the textbook outcomes (TO). A nomogram was developed to predict postoperative overall survival (OS) and recurrence-free survival (RFS) in LAGC patients. RESULTS: The study included 972 patients with LAGC. The overall TOO achievement rate was 67.1%. The TOO achievement rate was significantly higher in patients non-sarcopenia compared to those with sarcopenia (68.9% vs. 61.1%, P = 0.031). Logistic regression revealed that age ≥ 65, high ASA score, and sarcopenia were independent risk factors for TOO failure. Cox regression analysis identified TOO, sarcopenia, tumor size, differentiation, vascular invasion, pT stage, and pN stage as independent predictors of OS and RFS. Nomogram models based on sarcopenia and TOO accurately predicted the 3-year and 5-year OS and RFS. CONCLUSION: Preoperative sarcopenia was an independent predictor of TOO implementation. A prognostic prediction model that integrates preoperative sarcopenia and TOO, which outperforms the current staging system, can aid clinicians in effectively assessing the prognosis of patients with LAGC.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhong Q, Zheng ZF, Wu D, et al. Textbook oncological outcome of locally advanced gastric cancer patients with preoperative sarcopenia: a multicenter clinical study. Surg Endosc. 2024. PMID: 39548007. doi:10.1007/s00464-024-11397-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。